FDA Inspection 1202017 — Intermed Laboratories Private Limited

Intermed Laboratories Private Limited — FEI 3005202412

The FDA completed an inspection of Intermed Laboratories Private Limited on March 17, 2023 in Chennai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chennai (India)

Citations

IDCFRDescription
150421 CFR 211.122(d)Labels and labeling stored separately
200921 CFR 211.188Prepared for each batch, include complete information
202721 CFR 211.192Investigations of discrepancies, failures
239921 CFR 211.194(a)(2)Laboratory Test Method Verification
358521 CFR 211.110(a)Control procedures to monitor and validate performance
361621 CFR 211.165(d)Acceptance criteria for sampling & testing